BIOREMIA is the acronym of the project BIOfilm-REsistant Materials for hard tissue Implant Applications. The 4-years project is funded with about 4 Mio. Euro by the European Union in the framework of the of the Horizon 2020 Marie Skłodowska Curie Actions – Innovative Training Networks (ITN).
Implant-related infections caused by bacterial biofilms are a major cause of implant rejection. Since antibiotic treatments are controversially and ineffective for biofilm, new approaches to infection control focus on the development of preventive measures, for instance by acting on the implant material itself. The BIOREMIA mission is to inhibit microbial biofilm formation by developing biomaterials and coatings with enhanced antibacterial & antifouling functionality that will result in improved biological acceptance of bone-related implants. This should result in significantly better medical devices, which improve the quality of life of patients and reduce the economic burden on the health system.
The interdisciplinary BIOREMIA network brings together researchers in the fields of biomaterials, surface engineering, nanotechnology, physical metallurgy, medical technology, biochemistry and electrochemistry as well as microbiology. The industry-academia consortium consists of 11 partners from 10 European countries (Germany, Austria, Greece, Sweden, United Kingdom, Spain, Italy, Switzerland, Ireland and France). Together they will employ and train 15 PhD students.
Prof. Dr. Mariana Calin
Phone +49 351 4659 613